To test whether fructose binding/transport activity is involved in the enhanced motility of cancer cells, we introduced the E401A mutant of the human SLC2A5 into SLC2A5 gene-edited MIA-PaCa-2 or HT1080tdT cells. Here, SLC2A5 is linked to cancer.